1Hoch W. Formation of the neuromuscular junction. Agrin and its unusual receptors.Eur J Biochem, 1999, 265:1.
2Yamamoto T, Vincent A, Newsom-Davis J. Myasthenia gravis without acetylcholine-receptor antibody, a distinct disease entity.Lancet, 1986, 1:116.
3Poea S, Guyon T, Bidault J, et al. Modulation of acteylcholine receptor expression in seronegative myasthenia gravis. Ann Neurol, 2000, 48:696.
4Padua L, Stalberg E, LoMonaco M, et al.SFEMG in ocular myasthenia gravis diagnosis. Clin Neurophysiol, 2000, 111 : 1203.
5Valls-Canals J, Femminini R, Kochen S, et al. A cold test for myasthenia gravis. Neurology, 1979, 29:1075.
6Golnik KC, Pena R, Lee AG, et al. An ice test for the diagnosis of myasthenia gravis.Ophthalmology, 1999, 106:1282.
7Mygland A, Vincent A, Newsom-Davis J,et al. Autoantibidies in thymoma-associated myasthenia gravis with myositis or neuromyotonia. J AAPOS, 2000, 4:271.
8Romi F, Skeie GO, Aarli JA, et al. Muscle autoantibodies in subgroups of myasthenia gravis patients. J Neurol, 2000, 247:369.
9Romi F, Skeie GO, Vedeler C, et al. Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis.A study of IgG subclasses and clinical correlations. J Neuroimmunol, 2000, 111 : 169.
10Romi F, Skeie GO, Aarli JA, et al. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. Arch Neurol,2000, 57:1596.
同被引文献7
1杨明山 方思羽 等.神经科急症诊断治疗学[M].武汉:湖北科学技术出版社,1994.318.
2Rowland LP. controversies about the treatment of myasthenia gravis. J Neurol Neurosurg psychiatry, 1980,43(7) :644-659.
